Induction of autophagy-dependent apoptosis by the survivin suppressant YM155 in prostate cancer cells

被引:68
|
作者
Wang, Qinwen [1 ]
Chen, Zhengtang [1 ]
Diao, Xinwei [2 ]
Huang, Shengbing [3 ]
机构
[1] Third Mil Med Univ, Xinqiao Hosp, Oncol Res Inst, Chongqing 400037, Peoples R China
[2] Third Mil Med Univ, Xinqiao Hosp, Dept Pathol, Chongqing 400037, Peoples R China
[3] Mayo Clin, Mayo Canc Ctr, Rochester, MN 55905 USA
基金
中国国家自然科学基金;
关键词
Survivin; YM155; Autophagy; Apoptosis; TRAIL-MEDIATED APOPTOSIS; MONITORING AUTOPHAGY; BECLIN; PROTEINS; EXPRESSION; INHIBITOR; YEAST;
D O I
10.1016/j.canlet.2010.12.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this study, we demonstrated that YM155, a novel survivin suppressant, induced both apoptosis, and autophagy that was shown by conversion of cytosolic-associated protein light chain 3 (LC3I) into autophagosome-associated form (LC3II) and a punctate fluorescence pattern of an ectopic GFP-LC3 protein. The lysosomal inhibitor chloroquine further accumulated YM155-induced LC3II, indicating an increase of autophagic flux. Ectopic expression of survivin significantly attenuated YM155-induced apoptosis and autophagy, whereas suivivin siRNA induced autophagy. Furthermore, inhibition of either early or late events of autophagy attenuated YM155-induced apoptosis, demonstrating that induction of autophagy proceeds apoptosis. In conclusion, suppression of survivin by YM155 induces autophagy-dependent apoptosis, and YM155-induced autophagy plays a pro-apoptotic role thereby unveiling a novel mechanism of YM155 in prostate cancer cells. (C) 2010 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:29 / 36
页数:8
相关论文
共 50 条
  • [1] Induction of autophagy-dependent cell death by the survivin suppressant YM155 in salivary adenoid cystic carcinoma
    Yu-Fan Wang
    Wei Zhang
    Ke-Fei He
    Bing Liu
    Lu Zhang
    Wen-Feng Zhang
    Ashok B. Kulkarni
    Yi-Fang Zhao
    Zhi-Jun Sun
    Apoptosis, 2014, 19 : 748 - 758
  • [2] Induction of autophagy-dependent cell death by the survivin suppressant YM155 in salivary adenoid cystic carcinoma
    Wang, Yu-Fan
    Zhang, Wei
    He, Ke-Fei
    Liu, Bing
    Zhang, Lu
    Zhang, Wen-Feng
    Kulkarni, Ashok B.
    Zhao, Yi-Fang
    Sun, Zhi-Jun
    APOPTOSIS, 2014, 19 (04) : 748 - 758
  • [3] YM155 down-regulates survivin and XIAP, modulates autophagy and induces autophagy-dependent DNA damage in breast cancer cells
    Cheng, S. M.
    Chang, Y. C.
    Liu, C. Y.
    Lee, J. Y. C.
    Chan, H. H.
    Kuo, C. W.
    Lin, K. Y.
    Tsai, S. L.
    Chen, S. H.
    Li, C. F.
    Leung, E.
    Kanwar, J. R.
    Huang, C. C.
    Chang, J. Y.
    Cheung, C. H. A.
    BRITISH JOURNAL OF PHARMACOLOGY, 2015, 172 (01) : 214 - 234
  • [4] The survivin suppressant YM155 reverses doxorubicin resistance in osteosarcoma
    Zhang, Zhuo
    Zhang, Yunfeng
    Lv, Jiayin
    Wang, Jincheng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (10): : 18032 - 18040
  • [5] YM155 induces autophagy-dependent cell death in Tamoxifen-resistant breast cancer cells
    Liu, Chih-Yun
    Cheng, Siao Muk
    Leung, Euphemia
    Cheung, Chun Hei Antonio
    CANCER RESEARCH, 2013, 73 (08)
  • [6] Carrier-mediated uptake of YM155, a novel survivin suppressant, into human cancer cells in vitro
    Minematsu, Tsuyoshi
    Iwai, Megumi
    Nakahara, Takahito
    Usui, Takashi
    Kamimura, Hidetaka
    DRUG METABOLISM REVIEWS, 2006, 38 : 112 - 112
  • [7] Predicting response to sepantronium bromide (YM155), a survivin suppressant, by PET imaging with [11C]YM155
    Mitsuoka, Keisuke
    Kita, Aya
    Murakami, Yoshihiro
    Shirasuna, Kenna
    Noda, Akihiro
    Yamanaka, Kentaro
    Kaneko, Naoki
    Miyoshi, Sosuke
    NUCLEAR MEDICINE AND BIOLOGY, 2018, 64-65 : 41 - 46
  • [8] MEDI 312-Discovery of YM155, a novel survivin suppressant for the treatment of cancer
    Kinoyama, Isao
    Matsuhisa, Akira
    Nakahara, Takahito
    Takeuchi, Masahiro
    Shirasuna, Kenna
    Minematsu, Tsuyoshi
    Asai, Norio
    Matsumoto, Shunichiro
    Kawaguchi, Kenichi
    Kazami, Junichi
    Toyoshima, Akira
    Kita, Aya
    Tominaga, Fumiko
    Okada, Minoru
    Ohta, Mitsuaki
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234
  • [9] DECREASING SURVIVIN BY YM155 REVERSES CABAZITAXEL RESISTANCE IN PROSTATE CANCER
    Miyao, Takeshi
    Koike, Hidekazu
    Otsu, Akira
    Oka, Daisuke
    Aoki, Masanori
    Nakayama, Hiroshi
    Miyazawa, Yoshiyuki
    Arai, Seiji
    Sekine, Yoshitaka
    Matsui, Hiroshi
    Shibata, Yasuhiro
    Suzuki, Kazuhiro
    JOURNAL OF UROLOGY, 2020, 203 : E770 - E770
  • [10] Survivin suppressant YM155: A pharmacokinetic comparison between US and Japanese populations
    Cao, Ying J.
    Aoyama, Yumiko
    Kakihara, Toru
    Katashima, Masataka
    Sawamoto, Taiji
    Roy, Michael
    Wang, Jimmy
    Abeyratne, Anura
    Nakahara, Takahito
    Steinberg, Joyce
    Keating, Anne
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)